In murine models of uremic cachexia and renal fibrosis, the use of leptin antagonists significantly reduced levels of TGF-β1 mRNA, which can be coactivated by leptin to promote the development of muscle and renal fibrosis (Mak et al., 2018). This evidence concerns the gene LEP and renal fibrosis.